http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000513378-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 1998-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2000513378-A |
titleOfInvention | Quinolonecarboxylic acid derivatives |
abstract | (57) [Summary] The present invention relates to a quinolone carboxylic acid derivative which is superior to existing quinolone antibiotics and has a broad antibacterial activity. More specifically, a novel quinolone carboxylic acid represented by the following chemical formula 1 having a derivative of 7- [8- (alkoxyimino) -2,6-diazaspiro [3,4] oct-6-yl] as a substituent. It relates to acid derivatives, their pharmaceutically acceptable salts and their isomers. Here, A is C—H, C—F, C—Cl, C—O—CH 3 or N, Y is H or an amino group, R 1 is cyclopropyl or 2,4-difluorophenyl group, and R 2 is C 1 to 4 alkyl, R 3 is H or alkyl of C 1 to 4. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010523649-A |
priorityDate | 1997-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 121.